LV10917B - New use of bambuterol - Google Patents
New use of bambuterol Download PDFInfo
- Publication number
- LV10917B LV10917B LVP-93-816A LV930816A LV10917B LV 10917 B LV10917 B LV 10917B LV 930816 A LV930816 A LV 930816A LV 10917 B LV10917 B LV 10917B
- Authority
- LV
- Latvia
- Prior art keywords
- bambuterine
- lipid
- lowering
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9000948A SE9000948D0 (sv) | 1990-03-16 | 1990-03-16 | New use |
PCT/SE1991/000195 WO1991013615A1 (en) | 1990-03-16 | 1991-03-14 | New use of bambuterol |
Publications (2)
Publication Number | Publication Date |
---|---|
LV10917A LV10917A (lv) | 1995-12-20 |
LV10917B true LV10917B (en) | 1996-04-20 |
Family
ID=20378886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-93-816A LV10917B (en) | 1990-03-16 | 1993-06-30 | New use of bambuterol |
Country Status (28)
Country | Link |
---|---|
US (2) | US5837727A (ko) |
EP (1) | EP0521967B1 (ko) |
JP (1) | JP3081640B2 (ko) |
KR (1) | KR100194995B1 (ko) |
AT (1) | ATE138570T1 (ko) |
AU (1) | AU653149B2 (ko) |
CA (1) | CA2077762C (ko) |
CZ (1) | CZ279308B6 (ko) |
DE (1) | DE69119896T2 (ko) |
DK (1) | DK0521967T3 (ko) |
EG (1) | EG19645A (ko) |
ES (1) | ES2087291T3 (ko) |
GR (1) | GR3020700T3 (ko) |
HK (1) | HK52197A (ko) |
HU (1) | HU211998B (ko) |
IE (1) | IE80668B1 (ko) |
IL (1) | IL97509A (ko) |
LT (1) | LT3734B (ko) |
LV (1) | LV10917B (ko) |
MY (1) | MY114218A (ko) |
NZ (1) | NZ237279A (ko) |
PT (1) | PT97052B (ko) |
RU (1) | RU2093153C1 (ko) |
SE (1) | SE9000948D0 (ko) |
SG (1) | SG64895A1 (ko) |
SK (1) | SK278815B6 (ko) |
WO (1) | WO1991013615A1 (ko) |
ZA (1) | ZA911452B (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9000948D0 (sv) * | 1990-03-16 | 1990-03-16 | Draco Ab | New use |
US6459316B1 (en) * | 2000-12-08 | 2002-10-01 | Intel Corporation | Flip flop circuit |
EP1458374A2 (en) * | 2001-12-14 | 2004-09-22 | Novo Nordisk A/S | Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
US7495028B2 (en) | 2002-08-08 | 2009-02-24 | Wen Tan | R-bambuterol, its preparation and therapeutic uses |
ATE406887T1 (de) * | 2002-08-08 | 2008-09-15 | Wen Tan | R-bambuterol, seine herstellung und therapeutische verwendungen |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3163871D1 (en) * | 1980-07-09 | 1984-07-05 | Draco Ab | 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates |
US4472436A (en) * | 1982-12-06 | 1984-09-18 | Neo-Bionics, Inc. | Increasing HDL-cholesterol levels with phenylethylamine derivatives |
EP0244062A3 (en) * | 1986-03-03 | 1990-06-20 | Beecham Group Plc | Use of aryl ethanol amine derivatives in the treatment of atherosclerosis |
SE9000948D0 (sv) * | 1990-03-16 | 1990-03-16 | Draco Ab | New use |
-
1990
- 1990-03-16 SE SE9000948A patent/SE9000948D0/xx unknown
-
1991
- 1991-02-27 ZA ZA911452A patent/ZA911452B/xx unknown
- 1991-03-01 NZ NZ237279A patent/NZ237279A/en unknown
- 1991-03-11 IL IL9750991A patent/IL97509A/en not_active IP Right Cessation
- 1991-03-13 EG EG14791A patent/EG19645A/xx active
- 1991-03-13 MY MYPI91000414A patent/MY114218A/en unknown
- 1991-03-14 WO PCT/SE1991/000195 patent/WO1991013615A1/en active IP Right Grant
- 1991-03-14 SG SG1996005904A patent/SG64895A1/en unknown
- 1991-03-14 AU AU75691/91A patent/AU653149B2/en not_active Expired
- 1991-03-14 HU HU9202958A patent/HU211998B/hu unknown
- 1991-03-14 ES ES91906760T patent/ES2087291T3/es not_active Expired - Lifetime
- 1991-03-14 DE DE69119896T patent/DE69119896T2/de not_active Expired - Lifetime
- 1991-03-14 AT AT91906760T patent/ATE138570T1/de not_active IP Right Cessation
- 1991-03-14 JP JP03507053A patent/JP3081640B2/ja not_active Expired - Lifetime
- 1991-03-14 RU SU915053006A patent/RU2093153C1/ru active
- 1991-03-14 CA CA002077762A patent/CA2077762C/en not_active Expired - Lifetime
- 1991-03-14 DK DK91906760.3T patent/DK0521967T3/da active
- 1991-03-14 EP EP91906760A patent/EP0521967B1/en not_active Expired - Lifetime
- 1991-03-15 US US07/670,053 patent/US5837727A/en not_active Expired - Lifetime
- 1991-03-15 IE IE86291A patent/IE80668B1/en not_active IP Right Cessation
- 1991-03-15 CZ CS91681A patent/CZ279308B6/cs not_active IP Right Cessation
- 1991-03-15 SK SK681-91A patent/SK278815B6/sk unknown
- 1991-03-15 PT PT97052A patent/PT97052B/pt not_active IP Right Cessation
-
1992
- 1992-09-15 KR KR1019920702222A patent/KR100194995B1/ko not_active IP Right Cessation
-
1993
- 1993-06-30 LV LVP-93-816A patent/LV10917B/lv unknown
- 1993-12-30 LT LTIP1735A patent/LT3734B/lt not_active IP Right Cessation
-
1996
- 1996-07-31 GR GR960402068T patent/GR3020700T3/el unknown
-
1997
- 1997-04-24 HK HK52197A patent/HK52197A/xx not_active IP Right Cessation
-
1998
- 1998-11-17 US US09/193,940 patent/US6034123A/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2000249434B2 (en) | Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same | |
HK16488A (en) | 6(r)-(2-(8'-acyloxy-2'-methyl-6-methyl(or hydrogen)-polyhydronaphthyl-1')-ethyl)-4-(r)-hydroxy-3,4,5,6-tetrahydro-2h-pyran-2-ones,the hydroxy acid form of said pyranones,the pharmaceutically acceptable salts of said hydroxy acids,and the lower alkyl,and phenyl,dimethylamino or acetylamino substituted lower alkyl esters of said hydroxy acid,processes for preparing the same,and a pharmaceutical antihypercholesterolemic composition containing the same | |
PL323487A1 (en) | Three-phase pharmaceutic form of constant-rate controllable release of amorphous active ingredient for administration once per day | |
JP2004501121A5 (ko) | ||
NO872259L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive trans-6(2-(3-eller 4-karboksamido-substituert-pyrrol-1-yl)alkyl)-4-hydroksypyran-2-on-derivater. | |
TNSN90003A1 (fr) | Derives de 2-aminopyrimidinones utiles notamment comme antagonistes des neurotransmetteurs et procede pour leur preparation | |
LV10917B (en) | New use of bambuterol | |
IL95956A0 (en) | Benzoic acid derivatives and pharmaceutical compositions containing the same | |
ATE8047T1 (de) | (2-oxo-3-tetrahydrothienylcarbamoyl)-alkylthioessigs[ure, ihre salze und ester, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
AU8268591A (en) | Codeine salt of a substituted carboxylic acid, processes for the preparation thereof, its use and pharmaceutical compositions | |
CA2344053A1 (en) | Composition containing cinnamic acid derivatives for preventing or treating elevated blood lipid level-related diseases | |
AU3003189A (en) | 7(2-(2-aminothiazol-4-yl)-2-hydroxyimino-acetamido)-3- methoxymethyl-3-cephem-4-carboxylate ester derivatives | |
IL70560A (en) | Dialkylaminoalkoxybenzyl alcohol derivatives,their preparation and pharmaceutical compositions containing them | |
AU663998B2 (en) | Chondroprotective agents | |
ATE27270T1 (de) | Thioester von acetylsalicylsaeure, ein verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
NO177484C (no) | Fremgangsmåte for fremstilling av et farmasöytisk preparat i form av myke kapsler | |
CA2310318A1 (en) | Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetic acid dihydrochloride | |
ATE1855T1 (de) | Antiarthritische hydroxyessigsaeurederivate, pharmazeutische zusammensetzungen daraus und verfahren zu ihrer herstellung. | |
IE41219L (en) | Aralkyl esters of aminoalkanoic acids | |
JPH07507786A (ja) | 脂肪酸,例えばz−ヒドロキシミスチン酸の抗ウイルス剤としての使用 | |
DE3765124D1 (de) | Neue stickstoffarylmethoxy-thiophenderivate und deren saeureadditionssalze,verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
WO1987004435A3 (en) | Xanthine compounds | |
AU4239089A (en) | New 1,4-dihydropyridinederivative, namely (-)-2-{(2- aminoethoxy) ethoxy)-4-(2,3-dichlorophenyl)-3- ethoxycarbonyl-50methoxycarbonyl-6-methyl}-1,4- dihydropyridine, process for preparing it and pharmaceutical compositions containing it | |
NZ241455A (en) | Rubidium and caesium salts of diclofenac and pharmaceutical compositions thereof | |
IT1265108B1 (it) | Amidi di acidi biliari, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono |